Preclinical PREVENT Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers

Grant

Date/time Interval

  • April 1, 2020 - March 31, 2022

    • Awarded By

    Total Award Amount

  • 0.00

    • Direct Costs

  • 0.00

    • Sponsor Award Id

  • HHSN261201500036I

    • Contributor

  • Gregory Kennedy M.D.   Principal Investigator